Hims & Hers shares dropped 10.31% to $23.32 before its earnings report, which should show a profit of 6 cents per share.

Nov 9, 2026, 1:26 PM ETResultsRead the original at Benzinga

Neutral

Hims & Hers has not reported third-quarter results yet. Second-quarter sales beat forecasts and its 2026 sales forecast rose, but its loss was 37 cents per share versus 3 cents expected, leaving mixed signals.

HIMS · Hims & Hers Health Inc.

AI read · Neutral

The AI's read

The earlier report gave investors two different signals. Sales beat forecasts, but the per-share loss was much larger than expected. Subscribers grew 19% from a year earlier, and the company raised its 2026 sales forecast to $3.1 billion–$3.3 billion. Those earlier gains do not show whether third-quarter profit reached the expected $0.06 per share.

Get alerts for HIMS

Follow Hims & Hers Health Inc. (HIMS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HIMS

Free on the App Store and Google Play, or on the web.